New cancer therapy shows promise in Early-Stage trial
NCT ID NCT04106492
Summary
This study tested a new cancer treatment called SQ3370 in patients with advanced solid tumors that had spread or could not be removed by surgery. The main goals were to find a safe dose and see if the treatment could shrink tumors. It involved 53 patients with specific types of cancer, including certain sarcomas and head and neck cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Research Institute
Adelaide, South Australia, 5000, Australia
-
Chris O'Brien Lifehouse
Camperdown, New South Wales, 2050, Australia
-
City of Hope
Duarte, California, 91010, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Royal North Shore Hospital
Sydney, New South Wales, 2065, Australia
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
-
Stanford Cancer Center
Palo Alto, California, 94304, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.